Showing results (241-250 of 499) with videos related to

Sort By:
Pageof 50
Molecular Cancer Research : MCR|February 22, 2022
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL InhibitionMasum Rahman, Ian Olson, Moustafa Mansour, et al.
Journal of Neuro-Oncology|December 1, 2018
Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60Ramin A Morshed, Seunggu J Han, Shawn L Hervey-Jumper, et al.
Translational Oncology|September 25, 2017
Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing TumorAdam Autry, Joanna J Phillips, Stojan Maleschlijski, et al.
Neuro-Oncology|February 13, 2010
Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent gliomaWenting Wu, Kathleen R Lamborn, Jan C Buckner, et al.
Cancer|August 14, 2002
Clinical trial participation among patients enrolled in the Glioma Outcomes ProjectSusan M Chang, Fred G Barker, Meic H Schmidt, et al.
Journal of Neurosurgery|October 21, 2005
Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injuryJustin S Smith, Soonmee Cha, Mary Catherine Mayo, et al.
Journal of Neuro-Oncology|June 7, 2022
Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomasAdam W Autry, Marisa Lafontaine, Llewellyn Jalbert, et al.
Neuro-Oncology|August 21, 2008
Quality of life in low-grade glioma patients receiving temozolomideRaymond Liu, Karla Solheim, Mei-Yin Polley, et al.
Pageof 50